Many pros and cons, with most of them making sense.
My main concerns are:
1- the listing costs: would they be twice higher than the current ones ? or would they be able to get some synergy out of the two ?
2- the limited life of ACL: if, as per some postings, this entity was to disappear in say 5 years, it doesn't help making it a compelling proposition for investors or employees.
I have to say I liked the initial proposition of Fonda revenue funding the other initiatives, and thought that another sort of financing would have been enough to bridge the gap. And is what has driven my continuous investment in ACL.
I look forward to getting more details about the new offer.
- Forums
- ASX - By Stock
- TSN
- acl demerger
acl demerger
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online